
Janus Henderson Global Life Sciences Fund
Fund · US4710236716 · JAGLX (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 3,33 % | 25,15 % |
Company Profile for Janus Henderson Global Life Sciences Fund Fund
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
Company Data
Name Janus Henderson Global Life Sciences Fund
Company Janus Henderson Global Life Sciences Fund
Symbol JAGLX
Primary Exchange
NASDAQ

ISIN US4710236716
Asset Class Fund
Sector Financial Services
Industry Asset Management - Global
Market Capitalization 5 Mrd.
Country United States of America
Currency USD
Employees -
Address Janus Investment Fund,
IPO Date 1998-12-31
Dividends from 'Janus Henderson Global Life Sciences Fund'
Ex-Date | Dividend per Share |
---|---|
07.12.2023 | 0,05 USD |
20.12.2022 | 0,09 USD |
20.12.2021 | 0,79 USD |
17.12.2020 | 0,69 USD |
17.12.2019 | 0,44 USD |
18.12.2018 | 6,72 USD |
19.12.2017 | 0,15 USD |
19.12.2016 | 0,08 USD |
17.12.2015 | 0,13 USD |
17.12.2014 | 5,40 USD |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | JAGLX |
More Shares
Investors who Janus Henderson Global Life Sciences Fund hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.